BTMDbiote Corp.

BTMD Stock Price, Valuation & Chart | biote Corp.

Compare

$1.690+0.02 (+1.20%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Medical - Care Facilities BTMD intrinsic value BTMD calculated fair value vs price

Overview Financials Dividends Ratios

BTMD Historical price chart

BTMD Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization74.54M

PE Ratio15.36

EPS0.11

Trading Volume585.08K

Today's High/Low1.8/1.64

Dividend Yield0.00

52 Week High/Low3.62/1.27

Shares Outstanding44.11M

BTMD Financial Statement

BTMD Analyst ratings

BTMD Analysis & performance metrics

BTMD Company profile

biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize…

biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile…

BTMD Management team

Name

Position

Robert C. PetersonCFO

Chief Financial Officer

Marc D. Beer

Executive Chairman

Jade Beutler

Head of Nutraceuticals

Cory Rice D.O.

Chief Clinical Advisor & Member of Medical Advisory Board

Joel Pickering

Chief Marketing Officer

John J. OlsenCTO

Chief Information Officer

Bret ChristensenCEO

Chief Executive Officer & Director

James Elliott Gibbs II

Chief People Officer

Name

Position

Robert C. PetersonCFO

Chief Financial Officer

Marc D. Beer

Executive Chairman

Jade Beutler

Head of Nutraceuticals

Cory Rice D.O.

Chief Clinical Advisor & Member of Medical Advisory Board

Joel Pickering

Chief Marketing Officer

John J. OlsenCTO

Chief Information Officer

Bret ChristensenCEO

Chief Executive Officer & Director

James Elliott Gibbs II

Chief People Officer

Management Team

Robert C. PetersonCFO

Chief Financial Officer

Marc D. Beer

Executive Chairman

Jade Beutler

Head of Nutraceuticals

Cory Rice D.O.

Chief Clinical Advisor & Member of Medical Advisory Board

Joel Pickering

Chief Marketing Officer

John J. OlsenCTO

Chief Information Officer

Bret ChristensenCEO

Chief Executive Officer & Director

James Elliott Gibbs II

Chief People Officer

Management

Robert C. PetersonCFO

Chief Financial Officer

Marc D. Beer

Executive Chairman

Jade Beutler

Head of Nutraceuticals

Cory Rice D.O.

Chief Clinical Advisor & Member of Medical Advisory Board

Joel Pickering

Chief Marketing Officer

John J. OlsenCTO

Chief Information Officer

Bret ChristensenCEO

Chief Executive Officer & Director

James Elliott Gibbs II

Chief People Officer

Total 8 executives

BTMD Frequently asked questions

What is biote Corp. (BTMD) Stock Price?

Current stock price of biote Corp. (BTMD) stock is $1.690. The stock price is +1.20% higher in the session. The intraday range can be seen from this page. Volume of biote Corp. (BTMD) stock is 585.08K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the biote Corp. (BTMD) stock price going up or down today?

The stock price of biote Corp. (BTMD) can change with earnings, company news, and overall market sentiment. biote Corp. operates in the Healthcare / Medical - Care Facilities market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the biote Corp. stock expensive at its current price?

Whether biote Corp. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for BTMD on this page is 15.36. EPS on this page is 0.11. Compare those figures with peers and growth expectations before deciding if the current biote Corp. price is justified.

How has the stock price of biote Corp. (BTMD) performed historically?

Historical performance for biote Corp. (BTMD) is shown on the price chart on this page. Review multi-period moves alongside volume to see how BTMD reacted to past earnings and market events.

Should I buy biote Corp. (BTMD) stock, at this price?

Buying biote Corp. (BTMD) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.